BioMarin Announces First Quarter 2009 Financi...( Net Product Revenue Increase of 25% L...)

Net Product Revenue Increase of 25% Led by Naglazyme International Expansion

Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET)

NOVATO, Calif., April 30 /PRNewswire-FirstCall/ --

               Financial Highlights ($ in millions, except per share data)

    Item                                Q1 2009            Q1 2008 Comparison

    Total BioMarin Revenue              $74.0                23% increase
    Total Net Product Revenue           $71.9                25% increase
    Naglazyme Net Product Revenue       $39.4                42% increase
    Aldurazyme Net Sales by Genzyme     $36.8                No change
    Aldurazyme BioMarin Net Product
     Revenue                            $17.0                29% decrease*
    Kuvan Net Product Revenue           $15.5                168% increase
    GAAP Net Income (Loss)              $(13.2)              $1.7
    GAAP Net Income (Loss) per share    $(0.13) (basic       $0.02 (basic
                                                 and                and
                                                 diluted)           diluted)
    Non-GAAP Net Income                 $9.3                 $4.1
    Non-GAAP Net Income per share       $0.09 (basic         $0.04 (basic
                                               and                  and
                                               diluted)             diluted)

    * The decrease in Aldurazyme BioMarin net product revenue is
      attributable to the one-time transfer of a significant amount of
      Aldurazyme inventory in the first quarter of 2008 concurrent with the
      restructuring of the BioMarin/Genzyme LLC.  Total incremental product
      revenue totaled $9.5 million in the first quarter of 2008, compared to
      $2.5 million in the first quarter of 2009.  The number of patients on
      Aldurazyme therapy worldwide continues to increas
'/>"/>
SOURCE  BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Related biology technology :

1. BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET)
2. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
3. BioMarin to Present at the 4th Annual Citi Biotech Day
4. BioMarins Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA
5. BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
6. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
7. BioMarin to Present at the Piper Jaffray Healthcare Conference
8. BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
9. BioMarin to Present at the Credit Suisse Healthcare Conference
10. BioMarin Announces Third Quarter 2008 Financial Results
11. BioMarin Corrects Information Included in Bloomberg Article